World Journal of Clinical Cases - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Homepage

Online Submission

Number of total visits: 3512117

Number of visits today: 1247

Number of downloads: 2692472

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Lee SJ, Yang H, Kim WR, Lee YS, Lee WS, Kong SJ, Lee HJ, Kim JH, Cheon J, Kang B, Chon HJ, Kim C. STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer. J Immunother Cancer 2021;9:e002195. [PMID: 34145029 DOI: 10.1136/jitc-2020-002195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]

For:

Lee SJ, Yang H, Kim WR, Lee YS, Lee WS, Kong SJ, Lee HJ, Kim JH, Cheon J, Kang B, Chon HJ, Kim C. STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer. J Immunother Cancer 2021;9:e002195. [PMID: 34145029 DOI: 10.1136/jitc-2020-002195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]

Number	Citing Articles
1	Shen R, Liu D, Wang X, Guo Z, Sun H, Song Y, Wang D. DNA Damage and Activation of cGAS/STING Pathway Induce Tumor Microenvironment Remodeling. Front Cell Dev Biol 2021;9:828657. [PMID: 35265630 DOI: 10.3389/fcell.2021.828657] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2	Kim CG, Sang YB, Lee JH, Chon HJ. Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach. Int J Mol Sci 2021;22:8035. [PMID: 34360800 DOI: 10.3390/ijms22158035] [Reference Citation Analysis]
3	Park HS, Kim YM, Kim S, Lee WS, Kong SJ, Yang H, Kang B, Cheon J, Shin SJ, Kim C, Chon HJ. High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer. J Immunother Cancer 2021;9:e003353. [PMID: 34670828 DOI: 10.1136/jitc-2021-003353] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4	Gan Y, Li X, Han S, Liang Q, Ma X, Rong P, Wang W, Li W. The cGAS/STING Pathway: A Novel Target for Cancer Therapy. Front Immunol 2021;12:795401. [PMID: 35046953 DOI: 10.3389/fimmu.2021.795401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5	Yu R, Zhu B, Chen D. Type I interferon-mediated tumor immunity and its role in immunotherapy. Cell Mol Life Sci 2022;79:191. [PMID: 35292881 DOI: 10.1007/s00018-022-04219-z] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6	Kim CW, Chon HJ, Kim C. Combination Immunotherapies to Overcome Intrinsic Resistance to Checkpoint Blockade in Microsatellite Stable Colorectal Cancer. Cancers (Basel) 2021;13:4906. [PMID: 34638390 DOI: 10.3390/cancers13194906] [Reference Citation Analysis]
7	Ke X, Hu T, Jiang M. cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers. FASEB J 2022;36:e22029. [PMID: 34907606 DOI: 10.1096/fj.202101199R] [Reference Citation Analysis]